Appili Raises $17M For COVID Tests

Halifax biopharma company Appili Therapeutics has raised about $16.9 million to fund Canadian trials of influenza drug Favipiravir, which is owned by Japanese photography and biotech giant FUJIFILM Toyama Chemical Company.
The private placement comes in the wake of Appili’s $10.25 million raise in February of this year and is part of a surge in bioscience fundraising in Atlantic Canada.
Both